4th Glioblastoma Drug Development Summit

Accelerate the Practical Translation and Clinical Development of Meaningful Therapies for the Treatment of Glioblastoma and Other Life Threatening CNS TumorsGlioblastoma continues to be one of the most devasting diseases, with a severe lack of options available for treatment. Between drug delivery challenges, inefficient preclinical models and post-treatment recurrence, this is one of the most difficult tumors to develop treatments for.Returning as an in-person meeting after three years, leading experts in the field, from key decision makers in pharma and biotech to academic pioneers are excited to re-unite at the 4th Glioblastoma Drug Development Summit to celebrate successes, learn from failures and explore novel approaches in GBM drug development over the past 12 months.